OncoCyte (OCX) Reports FY Loss of $3.37
Get Alerts OCX Hot Sheet
Join SI Premium – FREE
OncoCyte (NASDAQ: OCX) reported FY EPS of ($3.37). Revenue for the year came in at $1.5 million.
For earnings history and earnings-related data on OncoCyte (OCX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share